HomeInsightsResults

Sms Pharmaceuticals Ltd Quarterly Result

Sms Pharmaceuticals Ltd Quarterly Result

stocks purchased

₹ 0.5 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

18.8 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

SMS Pharmaceuticals Ltd

NSE: SMSPHARMA

Net Profit

₹ 13.86

Last updated on: Nov 23, 2024

Key Highlights

  • The revenue of SMS Pharmaceuticals Ltd for the Sep '24 is ₹ 198.05 crore as compare to the Jun '24 revenue of ₹ 165.82 crore. This represent the growth of 19.436735%.
  • The ebitda of SMS Pharmaceuticals Ltd for the Sep '24 is ₹ 32.77 crore as compare to the Jun '24 ebitda of ₹ 34.88 crore. This represent the decline of -6.0493135%.
  • The net profit of SMS Pharmaceuticals Ltd for the Sep '24 is ₹ 13.86 crore as compare to the Jun '24 net profit of ₹ 16.37 crore. This represent the decline of -15.332932%.

Results Analysis

Market Price of SMS Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring SMS Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024241.25
21 Nov 2024239.75
19 Nov 2024250.95
18 Nov 2024255.1
14 Nov 2024262.35
13 Nov 2024260.4
12 Nov 2024271.65
11 Nov 2024280.65
08 Nov 2024295.65
07 Nov 2024305.7

Historical Revenue of SMS Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of SMS Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of SMS Pharmaceuticals Ltd

No data available

* All values are in crore

SMS Pharmaceuticals Ltd News Hub

News

SMS Pharmaceuticals to convene board meeting

SMS Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 8 Nove...

Read more

02 Nov 202412:49

News

SMS Pharmaceuticals to conduct AGM

SMS Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be...

Read more

08 Aug 202414:06

News

Board of SMS Pharmaceuticals approves incorporation of subsidiary company

The Board of SMS Pharmaceuticals at its meeting held on 05 August 2024 has approved to inc...

Read more

05 Aug 202417:53

News

SMS Pharmaceuticals schedules board meeting

SMS Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 Augu...

Read more

30 Jul 202410:50

News

Board of SMS Pharmaceuticals recommends final dividend

SMS Pharmaceuticals announced that the Board of Directors of the Company at its meeting he...

Read more

29 May 202416:05

News

SMS Pharmaceuticals to conduct board meeting

SMS Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 May...

Read more

28 May 202413:41

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQ's For Sms Pharmaceuticals Ltd Quarterly Result

What is the EPS of SMS Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of SMS Pharmaceuticals Ltd is 7.01. An EPS is the amount of net income attributed to each share of a common stock.

How is SMS Pharmaceuticals Ltd EPS calculated?

The EPS of SMS Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does SMS Pharmaceuticals Ltd report its EPS?

SMS Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence SMS Pharmaceuticals Ltd EPS?

Factors that influence the EPS of SMS Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can SMS Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in SMS Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*